Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03926975 · ClinicalTrials.gov registry record · NA
The Effect of a Scleral Lens on the Anterior Chamber Depth and Minimum Rim Width
A NA study of Ocular Hypertension, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT03926975 is a NA study of Ocular Hypertension that has completed, run by University of Houston. The registered enrollment target is 26 participants, below the 278-participant average among 54 other Ocular Hypertension trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03926975, a NA study of Ocular Hypertension, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the use of two instruments to measure changes in two ocular structures: 1) the anterior chamber depth (ACD) - measured using low coherence optical biometry, and 2) minimum rim width of the optic nerve head (MRW) - measured using optical coherence tomography. Changes in these ocular structures indicate fluctuations in intraocular pressure (IOP) and will be measured during scleral contact lens (SGP) wear to determine if SGP wear influences IOP. We hypothesize that a scleral lens increases the intraocular pressure (IOP) during active wear and that the ACD and MRW will also change.
Conditions Studied
Interventions
- DEVICE Scleral Lens
- OTHER No lens
Study Locations (1)
Texas
- University Eye Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2019-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03926975
The ClinicalTrials.gov registry entry for NCT03926975 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 278-participant average among 54 other Ocular Hypertension trials with a reported enrollment target (91% lower). The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ocular Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Scleral Lens is the first listed.
NCT03926975 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03926975 about?
NCT03926975 is a clinical study titled "The Effect of a Scleral Lens on the Anterior Chamber Depth and Minimum Rim Width". The purpose of this study is to evaluate the use of two instruments to measure changes in two ocular structures: 1) the anterior chamber depth (ACD) - measured using low coherence optical biometry, and 2) minimum rim width of the optic nerve head (MRW) - measured using optical coherence tomography. ...
What is the current status of trial NCT03926975?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-06-01. Estimated completion is 2019-08-30.
What conditions does trial NCT03926975 study?
This clinical trial studies the following conditions: Ocular Hypertension.
What interventions are being tested in trial NCT03926975?
The interventions under investigation include: Scleral Lens (DEVICE), No lens (OTHER).
Who is sponsoring clinical trial NCT03926975?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03926975 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ocular Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
RECRUITING · NA
-
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
RECRUITING · NA
-
Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects
COMPLETED · NA
-
DSLT for Reducing Medication in Glaucoma
RECRUITING
-
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
RECRUITING · Phase 4
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.